Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma

Published:2013-12 Issue:12 Volume:74 Page:1563-1574
ISSN:0198-8859
Container-title:Human Immunology
language:en
Short-container-title:Human Immunology

Author:

Andrade Mariléia Chaves,Ferreira Shirlene Barbosa Pimentel,Gonçalves Luciana C.,De-Paula Alfredo Maurício Batista,de Faria Elaine Speziali,Teixeira-Carvalho Andréa,Martins-Filho Olindo Assis

Publisher

Elsevier BV

Subject

General Medicine,Immunology,Immunology and Allergy

Reference35 articles.

1. Trends and spatial distribution of oral cancer mortality in Sao Paulo, Brazil;Antunes;Oral Oncol,2001

2. The epidemiology of oral and pharynx cancer in Brazil;Wunsch-Filho;Oral Oncol,2002

3. T-cell tumor interaction directs the development of immunotherapies in head and neck cancer;Albers;Clin Dev Immunol,2010

4. Cancer-related inflammation;Mantovani;Nature,2008

5. The immunobiology of cancer immunosurveillance and immunoediting;Dunn;Immunity,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HLA expression as a risk factor for metastases of cutaneous squamous-cell carcinoma in organ- transplant recipients;Human Immunology;2023-03

2. STATUS OF THE CELLULAR IMMUNITY IN CLEAN-UP WORKERS OF THE CHORNOBYL ACCIDENT AND PATIENTS WITH CANCER OF THE MOUTH CAVITY, ORAL AND LARYNGEAL PART OF THE PHARYNX;Проблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology;2022

3. Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: a multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG);Radiation Oncology;2021-07-31

4. Immuno-Oncological Biomarkers for Squamous Cell Cancer of the Head and Neck: Current State of the Art and Future Perspectives;Cancers;2021-04-04

5. IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers;OncoTargets and Therapy;2018-06